Dow Up 0.76% Nasdaq Up 0.69%

Relypsa, Inc. (RLYP)

-NasdaqGS
19.29 Down 0.46(2.33%) Oct 24, 4:00PM EDT
Prev Close:19.75
Open:19.76
Bid:19.29 x 2700
Ask:19.30 x 200
1y Target Est:52.00
Beta:N/A
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:19.29 - 19.94
52wk Range:11.55 - 52.74
Volume:87,939
Avg Vol (3m):228,132
Market Cap:655.78M
P/E (ttm):N/A
EPS (ttm):-3.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RLYP

Comparison

Symbol% ChgMkt Cap
RLYPDown 2.33%655.78M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.47
Quarterly EPS Est (Sep-14) :-0.63
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Relypsa, Inc., a pharmaceutical company, focuses on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular, and metabolic diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback